Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines Journal:Investigational New Drugs | 2013 | 75 | ||
Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma Journal:Investigational New Drugs | 2011 | 72 | ||
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models Journal:Cancer Letters | 2014 | 93 |